Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Evolent Health Announces Dan McCarthy Appointed as President, Frank J. Williams to Retire From Evolent's Board of Directors in 2023
Evolent Health, Inc. ( NYSE: EVH), announced today that New Century Health CEO Dan McCarthy has been named Evolent […]
Tri-anim Health Services Announces Exclusive Relationship to Distribute Brainscope's Breakthrough Technology for Mild Head Injury Including Concussion, Into Emergency Departments
Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, […]
Elephas Announces $41.5 Million in Series B Funding
Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]
Upfront Raises $10.5 Million in Oversubscribed Series C; Unveils Advanced Product Features
Patient engagement and access platform Upfront today announced an additional $10.5 million in funding to accelerate its growth and […]
H.E.L Group Strengthens Leadership Team to Focus on New Product Development and Enhanced Customer Support
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, […]
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]
PhoreMost Enters Multi-project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced […]
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
Dong-A ST and Beactica Therapeutics Mutually Agree to Conclude Oncology Collaboration
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, […]
Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer
Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more